Invention Grant
- Patent Title: Compositions and methods for inhibition of the JAK pathway
- Patent Title (中): 用于抑制JAK途径的组合物和方法
-
Application No.: US13750632Application Date: 2013-01-25
-
Publication No.: US08815848B2Publication Date: 2014-08-26
- Inventor: Hui Li , Sambaiah Thota , David Carroll , Ankush Argade , Kin Tso , Arvinder Sran , Jeffrey Clough , Holger Keim , Somasekhar Bhamidipati , Vanessa Taylor , Robin Cooper , Rajinder Singh , Brian Wong
- Applicant: Rigel Pharmaceuticals, Inc.
- Applicant Address: US CA South San Francisco
- Assignee: Rigel Pharmaceuticals, Inc.
- Current Assignee: Rigel Pharmaceuticals, Inc.
- Current Assignee Address: US CA South San Francisco
- Agency: Klarquist Sparkman, LLP
- Agent Travis Young
- Main IPC: C07D239/48
- IPC: C07D239/48 ; C07D285/22 ; A61K31/506
Abstract:
The invention encompasses compounds having formula I-V and the compositions and methods using these compounds in the treatment of conditions in which modulation of the JAK pathway or inhibition of JAK kinases, particularly JAK3, may be therapeutically useful.
Public/Granted literature
- US20130142807A1 COMPOSITIONS AND METHODS FOR INHIBITION OF THE JAK PATHWAY Public/Granted day:2013-06-06
Information query
